| Title |
The role of the pharmacist in the management of type 2 diabetes: current insights and future directions
|
|---|---|
| Published in |
Integrated Pharmacy Research and Practice, January 2017
|
| DOI | 10.2147/iprp.s103783 |
| Pubmed ID | |
| Authors |
Jeffery David Hughes, Yosi Wibowo, Bruce Sunderland, Kreshnik Hoti |
| Abstract |
Type 2 diabetes is a chronic disease occurring in ever increasing numbers worldwide. It contributes significantly to the cost of health globally; however, its management remains in the most part less than optimal. Patients must be empowered to self-manage their disease, and they do this in partnership with health care professionals. Whilst the traditional role of the pharmacist has been centered around the supply of medicines and patient counseling, there is an evergrowing body of evidence that pharmacists, through a range of extended services, may contribute positively to the clinical and humanistic outcomes of those with diabetes. Further, these services can be delivered cost-effectively. This paper provides a review of the current evidence supporting the role of pharmacists in diabetes care, whilst providing a commentary of the future roles of pharmacists in this area. |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Australia | 3 | 50% |
| Indonesia | 1 | 17% |
| Unknown | 2 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 67% |
| Scientists | 2 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 189 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 189 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 34 | 18% |
| Student > Bachelor | 30 | 16% |
| Student > Ph. D. Student | 14 | 7% |
| Other | 8 | 4% |
| Researcher | 8 | 4% |
| Other | 26 | 14% |
| Unknown | 69 | 37% |
| Readers by discipline | Count | As % |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutical Science | 65 | 34% |
| Medicine and Dentistry | 20 | 11% |
| Nursing and Health Professions | 8 | 4% |
| Biochemistry, Genetics and Molecular Biology | 5 | 3% |
| Social Sciences | 4 | 2% |
| Other | 17 | 9% |
| Unknown | 70 | 37% |
Attention Score in Context
This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 November 2020.
All research outputs
#2,227,738
of 23,098,660 outputs
Outputs from Integrated Pharmacy Research and Practice
#14
of 102 outputs
Outputs of similar age
#47,831
of 421,638 outputs
Outputs of similar age from Integrated Pharmacy Research and Practice
#4
of 7 outputs
Altmetric has tracked 23,098,660 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 102 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.7. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 421,638 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.